Xspray

Xspray Pharma is a pharmaceutical company with multiple candidate products in clinical development. Xspray Pharma utilizes its innovative patented RightSize™ technology to develop improved versions of marketed drugs, primarily protein kinase inhibitors (PKI) for cancer treatment. The company's innovative technology positions Xspray Pharma as the first competitor to original drugs before the expiration of secondary patents. Xspray aims to become a leader in the development of improved PKI drugs for cancer treatment that are already on the market.